PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma. by Brault, L, Menter, T, Obermann, E, Knapp, S, Thommen, S, Schwaller, J, Tzankov, A

PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers. by Brault, L, Gasser, C, Bracher, F, Huber, K, Knapp, S, Schwaller, J

PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma by Brault, L, Menter, T, Obermann, E, Knapp, S, Thommen, S, Schwaller, J, Tzankov, A

STUDYING THE ROLE OF PIM KINASES IN FLT3-ITD-INDUCED LEUKEMIA REVEALED PIM1 AS REGULATOR OF CXCL12/CXCR4-MEDIATED HOMING AND MIGRATION by Brault, L, Grundler, R, Gasser, C, Bullock, A, Ehret, S, Spoo, A, Dierks, C, Biondi, A, Knapp, S, Duyster, J, Schwaller, J

7,8-dichloro-1-oxo-β-carbolines as a versatile scaffold for the development of potent and selective kinase inhibitors with unusual binding modes. by Huber, K, Brault, L, Fedorov, O, Gasser, C, Filippakopoulos, P, Bullock, A, Fabbro, D, Trappe, J, Schwaller, J, Knapp, S, Bracher, F

Dissecting Proto-Oncogenic PIM Serine/Threonine Kinases in FLT3-ITD-Induced Leukemogenesis: PIM1 Regulates CXCL12/CXCR4-Mediated Homing and Migration by Gasser, C, Grundler, R, Brault, L, Bullock, A, Dechow, T, Nawijn, M, Woetzel, S, Ehret, S, Berridge, G, Spoo, A, Dierks, C, Biondi, A, Knapp, S, Duyster, J, Schwaller, J

High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors. by Miduturu, C, Deng, X, Kwiatkowski, N, Yang, W, Brault, L, Filippakopoulos, P, Chung, E, Yang, Q, Schwaller, J, Knapp, S, King, R, Lee, J, Herrgard, S, Zarrinkar, P, Gray, N

Dissection of PIM serine/threonine kinases in FLT3-ITD-induced leukemogenesis reveals PIM1 as regulator of CXCL12-CXCR4-mediated homing and migration. by Grundler, R, Brault, L, Gasser, C, Bullock, A, Dechow, T, Woetzel, S, Pogacic, V, Villa, A, Ehret, S, Berridge, G, Spoo, A, Dierks, C, Biondi, A, Knapp, S, Duyster, J, Schwaller, J